Dynorphin, stress, and depression
Open accessAbstract
Stress is most often associated with aversive states. It rapidly induces the release of hormones and neuropeptides including dynorphin, which activates kappa opioid receptors (KORs) in the central and peripheral nervous systems. In animal models, many aversive effects of stress are mimicked or exacerbated by stimulation of KORs in limbic brain regions. Although KOR signaling during acute stress may increase physical ability (by producing analgesia) and motivation to escape a threat (by producing aversion), prolonged KOR signaling in response to chronic or uncontrollable stress can lead to persistent expression of behavioral signs that are characteristic of human depressive disorders (i.e., "prodepressive-like" signs). Accumulating evidence suggests that KORs contribute to the progressive amplification (sensitization) of stress-induced behaviors that occurs with repeated exposure to stress. Many of the aversive effects of stress are blocked by KOR antagonists, suggesting that these agents may have potential as therapeutics for stress-related conditions such as depression and anxiety disorders. This review summarizes current data on how KOR systems contribute to the acute (rapid), delayed, and cumulative molecular and behavioral effects of stress. We focus on behavioral paradigms that provide insight on interactions between stress and KOR function within each of these temporal categories. Using a simplified model, we consider the time course and mechanism of KOR-mediated effects in stress and suggest future directions that may be useful in determining whether KOR antagonists exert their therapeutic effects by preventing the development of stress-induced behaviors, the expression of stress-induced behaviors, or both.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cell subtype enriched peptides such as dynorphin and enkephalin play a role in depression.
“Among the many neuropeptides found within the NAc, cell subtype enriched peptides such as dynorphin and enkephalin play a role in depression (71, 72).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [71]
Buprenorphine blocks the action of kappa agonists, and functional kappa antagonism has been proposed from animal models to function therapeutically as an antidepressant compound in humans.
“In addition, BUP has also been shown to block the action of k agonists [56] and a functional k antagonism has been proposed on the basis of the results derived by animal models to function therapeutically as an antidepressant compound in humans [24]”
From The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review (2018) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · see citing works
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · see citing works
Depression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
Meaney, M. J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1161 · Cited by 2,708 · see citing works
THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 2× · see citing works
“However, prolonged KOR signaling in response to chronic or uncontrollable stress may lead to persistent changes in behavior that are characteristic of those seen in human depressive disorders (see Kessler, 1997; Nestler and Carlezon, 2006; Pittenger and Duman, 2008).”
BackgroundSTRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · see citing works
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · see citing works
Self-citationKalivas, P. W., & Stewart, J. (1991) · Brain Research Reviews · doi:10.1016/0165-0173(91)90007-u · Cited by 2,021 · see citing works
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968 · see citing works
Chronic stress, drug use, and vulnerability to addiction
Sinha, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.030 · Cited by 1,904 · see citing works
McEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864 · see citing works
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · see citing works
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610 · see citing works
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F. M., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,605 · see citing works
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454 · see citing works
Detke, M. J., Rickels, M. R., & Lucki, I. (1995) · Psychopharmacology · doi:10.1007/bf02245592 · Cited by 1,438 · see citing works
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397 · see citing works
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 2× · see citing works
“HIP volumes are reduced in individuals with posttraumatic stress disorder (Bremner et al., 1995; Woon and Hedges, 2008) and major depression (Sheline et al., 1999), and smaller HIP volumes are also predictive of vulnerability to develop stress-related disorders (Pitman et al., 2006).”
BackgroundCarlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,351 · see citing works
Self-citationWhy stress is bad for your brain
Sapolsky, R. M. (1996) · Science · doi:10.1126/science.273.5276.749 · Cited by 1,306 · cited 1× · see citing works
“…the time course of the HPA axis stress response (de Kloet et al., 2005), prolonged glucocorticoid signaling can damage the HIP as measured by dendritic atrophy, decreased neurogenesis, and deficits in synaptic plasticity (McEwen and Gould, 1990; Sapolsky, 1996; McEwen, 1999; Meaney, 2001).”
BackgroundOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,297 · see citing works
Psychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272 · see citing works
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · see citing works
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & D, A. G. M. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,171 · see citing works
Abercrombie, E. D., Keefe, K. A., DiFrischia, D. S., & Zigmond, M. J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09224.x · Cited by 1,106 · see citing works
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · see citing works
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005 · see citing works
Dendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945 · see citing works
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916 · see citing works
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · see citing works
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767 · see citing works
Self-citationKelley, A. E., & Domesick, V. B. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90198-1 · Cited by 746 · see citing works
Maier, S. F., & Watkins, L. R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.021 · Cited by 737 · see citing works
The amygdala and persistent pain
Neugebauer, V., Li, W., Bird, G. C., & Han, J. S. (2004) · The Neuroscientist · doi:10.1177/1073858403261077 · Cited by 719 · see citing works
Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672 · see citing works
Neuroimaging studies of mood disorder effects on the brain
Sheline, Y. I. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00347-0 · Cited by 660 · see citing works
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · see citing works
Hökfelt, T. G. M., Broberger, C., Xu, Q., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 607 · see citing works
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601 · see citing works
Role of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570 · see citing works
Convergent regulation of locus coeruleus activity as an adaptive response to stress
Valentino, R. J., & Van Bockstaele, E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.062 · Cited by 569 · see citing works
Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis
Carlezon, W. A., & Thomas, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.075 · Cited by 561 · see citing works
Self-citationThe Psychophysiology of Sensation Seeking
Zuckerman, M. (1990) · Journal of Personality · doi:10.1111/j.1467-6494.1990.tb00918.x · Cited by 556 · see citing works
The Influence of Stress Hormones on Fear Circuitry
Rodrigues, S. M., LeDoux, J. E., & Sapolsky, R. M. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135620 · Cited by 556 · see citing works
Distribution of dynorphin and enkephalin peptides in the rat brain
Fallon, J. H., & Leslie, F. M. (1986) · The Journal of Comparative Neurology · doi:10.1002/cne.902490302 · Cited by 526 · see citing works
Bals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 525 · see citing works
Parallel circuits mediating distinct emotional coping reactions to different types of stress
Keay, K. A., & Bandler, R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00049-5 · Cited by 512 · see citing works
How opioids inhibit GABA-mediated neurotransmission
Vaughan, C. W., Ingram, S., Connor, M. A., & Christie, M. J. (1997) · Nature · doi:10.1038/37610 · Cited by 510 · see citing works
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · see citing works
Self-citationBarrot, M., Olivier, J. D. A., Perrotti, L. I., DiLeone, R. J., Berton, O., Eisch, A. J., Impey, S., Storm, D. R., Neve, R. L., Yin, J. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172091899 · Cited by 508 · see citing works
Heim, C., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00224-3 · Cited by 502 · see citing works
Tidey, J. W., & Miczek, K. A. (1996) · Brain Research · doi:10.1016/0006-8993(96)00159-x · Cited by 496 · see citing works
Kim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494 · see citing works
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485 · see citing works
Self-citationDissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y. Q., Contet, C., Mennicken, F., O’Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 463 · see citing works
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 458 · see citing works
Goldberg, Y. P., MacFarlane, J., MacDonald, M., et al. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00790.x · Cited by 457 · see citing works
Direct Activation of the Ventral Striatum in Anticipation of Aversive Stimuli
Jensen, J., McIntosh, A. R., Crawley, A. P., Mikulis, D. J., Remington, G., & Kapur, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00724-4 · Cited by 455 · see citing works
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 432 · see citing works
Interaction between glucocorticoid hormones, stress and psychostimulant drugs*
Marinelli, M., & Piazza, P. V. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02089.x · Cited by 427 · see citing works
Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418 · see citing works
Woon, F. L., & Hedges, D. W. (2008) · Hippocampus · doi:10.1002/hipo.20437 · Cited by 416 · see citing works
Dellu-Hagedorn, F., Piazza, P. V., Mayo, W., Moal, M. L., & Simon, H. (2008) · Neuropsychobiology · doi:10.1159/000119305 · Cited by 394 · see citing works
Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092304 · Cited by 390 · see citing works
Self-citationBrain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388 · see citing works
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation
Carlezon, W. A., & Chartoff, E. H. (2007) · Nature Protocols · doi:10.1038/nprot.2007.441 · Cited by 368 · see citing works
Self-citationCole, R. L., Konradi, C. L., DOUGLASS, J. O., & Hyman, S. E. (1995) · Neuron · doi:10.1016/0896-6273(95)90225-2 · Cited by 365 · see citing works
Congenital insensitivity to pain: an update
Nagasako, E. M., Oaklander, A. L., & Dworkin, R. H. (2003) · Pain · doi:10.1016/s0304-3959(02)00482-7 · Cited by 358 · see citing works
Kabbaj, M., Devine, D. P., Savage, V. R., & Akil, H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06983.2000 · Cited by 350 · see citing works
Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli
Roitman, M. F., Wheeler, R. A., Wightman, R. M., & Carelli, R. M. (2008) · Nature Neuroscience · doi:10.1038/nn.2219 · Cited by 343 · see citing works
Rice, M. E., & Cragg, S. J. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.004 · Cited by 340 · see citing works
Weisskopf, M. G., Zalutsky, R. A., & Nicoll, R. A. (1993) · Nature · doi:10.1038/362423a0 · Cited by 337 · see citing works
Extended Amygdala and Basal Forebrain
Alheid, G. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07082.x · Cited by 334 · see citing works
A Specialized Subclass of Interneurons Mediates Dopaminergic Facilitation of Amygdala Function
Marowsky, A., Yanagawa, Y., Obata, K., & Vogt, K. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.029 · Cited by 328 · see citing works
κ opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., & Fields, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511159103 · Cited by 326 · see citing works
Serotonergic modulation of the limbic system
Hensler, J. G. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.06.007 · Cited by 319 · see citing works
Role of perirhinal cortex in object perception, memory, and associations
Murray, E. A., & Richmond, B. J. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00195-1 · Cited by 319 · see citing works
Yuan, L., Adams, J. P., Swank, M. W., Sweatt, J. D., & Johnston, D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04860.2002 · Cited by 314 · see citing works
Chen, A. C. H., Shirayama, Y., Shin, K.-H., Neve, R. L., & Duman, R. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01114-8 · Cited by 314 · see citing works
Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313 · see citing works
Beardsley, P. M., Howard, J. L., Shelton, K. L., & Carroll, F. I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0167-4 · Cited by 312 · see citing works
Dopaminergic Innervation of the Amygdala Is Highly Responsive to Stress
Inglis, F., & Moghaddam, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721088.x · Cited by 310 · see citing works
Piazza, P. V., Deroche‐Gamonet, V., Deminière, J.-M., Maccari, S., Moal, M. L., & Simon, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11738 · Cited by 310 · see citing works
Shirayama, Y., Ishida, H., Iwata, M., Hazama, G., Kawahara, R., & Duman, R. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02589.x · Cited by 305 · see citing works
Pronociceptive actions of dynorphin maintain chronic neuropathic pain
Wang, Z., Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Brennan, M. B., Hochgeschwender, U., Hruby, V. J., Malan, T. P., Lai, J., & Porreca, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01779.2001 · Cited by 301 · see citing works
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 290 · see citing works
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala
Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300858 · Cited by 289 · see citing works
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 282 · see citing works
κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09981.2003 · Cited by 276 · see citing works
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1680-y · Cited by 273 · see citing works
Self-citationPeckys, D. B., & Landwehrmeyer, G. B. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00251-6 · Cited by 273 · see citing works
Wagner, J. J., Terman, G. W., & Chavkin, C. (1993) · Nature · doi:10.1038/363451a0 · Cited by 272 · see citing works
Pharmacology of Antidepressants
Frazer, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704001-00002 · Cited by 269 · see citing works
Role of ERK in cocaine addiction
Lü, L., Koya, E., Zhai, H., Hope, B. T., & Shaham, Y. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.10.005 · Cited by 269 · see citing works
Chiara, G. D., Loddo, P., & Tanda, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00236-x · Cited by 266 · see citing works
Serotonergic Systems, Anxiety, and Affective Disorder
Lowry, C. A., Hale, M. W., Evans, A. K., Heerkens, J., Staub, D. R., Gasser, P. J., & Shekhar, A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.004 · Cited by 265 · see citing works
Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors
Gutkind, J. S. (2000) · Science s STKE · doi:10.1126/stke.2000.40.re1 · Cited by 265 · see citing works
Bruchas, M. R., Macey, T. A., Lowe, J., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513640200 · Cited by 259 · see citing works
Wanat, M. J., Hopf, F. W., Stuber, G. D., Phillips, P. E. M., & Bonci, A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.150078 · Cited by 256 · see citing works
Millan, M. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.038 · Cited by 255 · see citing works
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System
McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., & Chavkin, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300872 · Cited by 253 · see citing works
Petrovich, G. D., & Swanson, L. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01361-3 · Cited by 234 · see citing works
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Redila, V. A., & Chavkin, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1122-y · Cited by 234 · see citing works
Walker, D. L., & Davis, M. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0183-3 · Cited by 231 · see citing works
Knoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 227 · see citing works
Self-citationMcLaughlin, J. P., Land, B. B., Li, S., Pintar, J. E., & Chavkin, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300860 · Cited by 226 · see citing works
Horan, P. J., Taylor, J., Yamamura, H. I., & Porreca, F. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11434-1 · Cited by 215 · see citing works
μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward
Walters, C. L., Cleck, J. N., Kuo, Y., & Blendy, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.005 · Cited by 209 · see citing works
Endoh, T., Matsuura, H., Tanaka, C., & Nagase, H. (1992) · PubMed · Cited by 206 · see citing works
Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206 · see citing works
Shaw-Lutchman, T. Z., Barrot, M., Wallace, T. L., Gilden, L., Zachariou, V., Impey, S., Duman, R. S., Storm, D. R., & Nestler, E. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03663.2002 · Cited by 205 · see citing works
Malan, P. T., Ossipov, M. H., Gardell, L. R., Ibrahim, M. M., Bian, D., Lai, J. Y., & Porreca, F. (2000) · Pain · doi:10.1016/s0304-3959(00)00243-8 · Cited by 200 · see citing works
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2087-0 · Cited by 196 · see citing works
Shippenberg, T. S., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91571-x · Cited by 190 · see citing works
Bruchas, M. R., Yang, T., Schreiber, S., DeFino, M. C., Kwan, S. C., Li, S., & Chavkin, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705540200 · Cited by 184 · see citing works
Pitman, R. K., Gilbertson, M. W., Gurvits, T. V., May, F. S., Lasko, N. B., Metzger, L. J., Shenton, M. E., Yehuda, R., Orr, S. P., & for the Harvard/VA PTSD Twin Study Investigators (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.019 · Cited by 178 · see citing works
State-dependent Ras signaling and AMPA receptor traffickingPreprint
Qin, Y., Zhu, Y., Baumgart, J. P., Stornetta, R. L., Seidenman, K. J., Mack, V., Aelst, L. V., & Zhu, J. (2005) · Genes & Development · doi:10.1101/gad.342205 · Cited by 177 · see citing works
Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor
Pan, Z. Z., Tershner, S., & Fields, H. L. (1997) · Nature · doi:10.1038/38730 · Cited by 176 · see citing works
Belcheva, M. M., Clark, A. L., Haas, P. D., Serna, J. S., Hahn, J. W., Kiss, A., & Coscia, C. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502593200 · Cited by 173 · see citing works
Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics
Mathew, S. J., Price, R. B., & Charney, D. S. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30172 · Cited by 168 · see citing works
The Role of Mu- and Kappa-Opioid Receptors in Cocaine-Induced Conditioned Place Preference
Suzuki, T., Shiozaki, Y., Masukawa, Y., Misawa, M., & Nagase, H. (1992) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.58.435 · Cited by 167 · see citing works
Wittmann, W., Schunk, E., Rosskothen, I., Gaburro, S., Singewald, N., Herzog, H., & Schwarzer, C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.142 · Cited by 165 · see citing works
Pattern of use and subjective effects of Salvia divinorum among recreational users
González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.001 · Cited by 163 · see citing works
Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens
Barrot, M., Wallace, D. L., Bolaños, C. A., Graham, D. L., Perrotti, L. I., Neve, R. L., Chambliss, H., Yin, J. C. P., & Nestler, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500587102 · Cited by 162 · see citing works
Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions
Shen, C., Tsimberg, Y., Salvadore, C., & Meller, E. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-36 · Cited by 161 · see citing works
Cellular Sites for Dynorphin Activation of κ-Opioid Receptors in the Rat Nucleus Accumbens Shell
Svingos, A. L., Colago, E. E. O., & Pickel, V. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01804.1999 · Cited by 157 · see citing works
Kappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 156 · see citing works
Self-citationXu, M., Petraschka, M., McLaughlin, J. P., Westenbroek, R. E., Caron, M. G., Lefkowitz, R. J., Czyzyk, T. A., Pintar, J. E., Terman, G. W., & Chavkin, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5552-03.2004 · Cited by 156 · see citing works
Mattson, B. J., Bossert, J. M., Simmons, D. E., Nozaki, N., Nagarkar, D. R., Kreuter, J. D., & Hope, B. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03500.x · Cited by 151 · see citing works
Ribeiro, S. C. M., Kennedy, S. E., Smith, Y. R., Stohler, C. S., & Zubieta, J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.011 · Cited by 147 · see citing works
Stress and Addiction: Biological and Psychological Mechanisms.
Al’Absi, M. (2007) · Cited by 144 · see citing works
Drake, C., Terman, G. W., Simmons, M., Milner, T. A., Kunkel, D. D., Schwartzkroin, P. A., & Chavkin, C. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03736.1994 · Cited by 142 · see citing works
Carey, A. N., Borozny, K., Aldrich, J. V., & McLaughlin, J. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.007 · Cited by 140 · see citing works
Nikolarakis, K. E., Almeida, O. F. X., & Herz, A. (1986) · Brain Research · doi:10.1016/0006-8993(86)90610-4 · Cited by 136 · see citing works
Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression
Yadid, G., Overstreet, D. H., & Zangen, A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03248-0 · Cited by 135 · see citing works
cAMP Response Element-Binding Protein Is Required for Stress But Not Cocaine-Induced Reinstatement
Kreibich, A. S., & Blendy, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1706-04.2004 · Cited by 134 · see citing works
Wallace, T. L., Stellitano, K. E., Neve, R. L., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.010 · Cited by 133 · see citing works
Opioid systems in the dentate gyrus
Drake, C. T., Chavkin, C., & Milner, T. A. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63015-5 · Cited by 130 · see citing works
Turgeon, S. M., Pollack, A. E., & Fink, J. S. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01316-9 · Cited by 129 · see citing works
Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System
Tao, R., & Auerbach, S. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037861 · Cited by 126 · see citing works
Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist
Carroll, I. F., Thomas, J. B., Dykstra, L., Granger, A. L., Allen, R. M., Howard, J. L., Pollard, G. T., Aceto, M. D. G., & Harris, L. S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.028 · Cited by 125 · see citing works
Comorbidity of pain and anxiety disorders
Gureje, O. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0051-0 · Cited by 125 · see citing works
Roth, K. A., Weber, E., Barchas, J. D., Chang, D., & Chang, J. (1983) · Science · doi:10.1126/science.6129700 · Cited by 124 · see citing works
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
Aldrich, J. V., & McLaughlin, J. P. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9105-4 · Cited by 124 · see citing works
Marchant, N. J., Densmore, V. S., & Osborne, P. B. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21464 · Cited by 123 · see citing works
A Review of the Properties of Spiradoline: A Potent and Selective k‐Opioid Receptor Agonist
Wadenberg, M.-L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00248.x · Cited by 123 · see citing works
Making a bad thing worse: adverse effects of stress on drug addiction
Cleck, J. N., & Blendy, J. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33946 · Cited by 122 · see citing works
McLaughlin, J. P., Myers, L. C., Zarek, P. E., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305796200 · Cited by 120 · see citing works
Hjelmstad, G. O., & Fields, H. L. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01115.2002 · Cited by 119 · see citing works
Carlezon, W. A., Wise, R. A., & Carlezon, W. A. (1996) · Psychopharmacology · doi:10.1007/s002130050151 · Cited by 119 · see citing works
Self-citationModulation of Anxiety-Like Behavior and Morphine Dependence in CREB-Deficient Mice
Valverde, O., Mantamadiotis, T., Torrecilla, M., Ugedo, L., Pineda, J., Bleckmann, S. C., Gass, P., Kretz, O., Mitchell, J., Schütz, G., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300416 · Cited by 118 · see citing works
Inflammatory pain is enhanced in delta opioid receptor‐knockout mice
Gavériaux‐Ruff, C., Karchewski, L. A., Hever, X. C., Matifas, A., & Kieffer, B. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06223.x · Cited by 116 · see citing works
Long-Term Effects of Brief Acute Stress on Cellular Signaling and Hippocampal LTP
Ahmed, T., Frey, J. U., & Korz, V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4901-05.2006 · Cited by 111 · see citing works
Meloni, E. G., Gerety, L. P., Knoll, A. T., Cohen, B. M., & Carlezon, W. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4957-05.2006 · Cited by 109 · see citing works
Rusin, K. I., Giovannucci, D. R., Stuenkel, E. L., & Moises, H. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-17-06565.1997 · Cited by 107 · see citing works
Meller, E., Shen, C., Nikolao, T. A., Jensen, C. H., Tsimberg, Y., Chen, J., & Gruen, R. J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02866-x · Cited by 105 · see citing works
Kreibich, A., Reyes, B. A. S., Curtis, A. L., Ecke, L. E., Chavkin, C., Bockstaele, E. J. V., & Valentino, R. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0390-08.2008 · Cited by 104 · see citing works
Xu, M., Bruchas, M. R., Ippolito, D. L., Gendron, L., & Chavkin, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-06.2007 · Cited by 104 · see citing works
Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain
Hurd, Y. L. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00002-4 · Cited by 99 · see citing works
Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla
Gutstein, H. B., Mansour, A., Watson, S. J., Akil, H., & Fields, H. L. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00019 · Cited by 99 · see citing works
Valdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99 · see citing works
Brown, C. H., & Bourque, C. W. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063818 · Cited by 95 · see citing works
Control of hormonal stress reactivity by the endogenous opioid system
Bilkei‐Gorzó, A., Rácz, I., Michel, K., Mauer, D., Zimmer, A. M., Klingmüller, D., & Zimmer, A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.010 · Cited by 93 · see citing works
Endogenous κ Opioid Activation Mediates Stress-Induced Deficits in Learning and Memory
Carey, A. N., Lyons, A. M., Shay, C. F., Dunton, O., & McLaughlin, J. P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6146-08.2009 · Cited by 92 · see citing works
The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward
Tomasiewicz, H. C., Todtenkopf, M. S., Chartoff, E. H., Cohen, B. M., & Carlezon, W. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.029 · Cited by 90 · see citing works
Self-citationThe role of CRF in the release of ACTH by opiate agonists and antagonists in rats
Nikolarakis, K. E., Pfeiffer, A. F. H., Stalla, G. K., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91311-4 · Cited by 90 · see citing works
McLennan, G., Kiss, A., Miyatake, M., Belcheva, M. M., Chambers, K. T., Pozek, J. J., Mohabbat, Y., Moyer, R. A., Bohn, L., & Coscia, C. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05745.x · Cited by 89 · see citing works
Both Kappa and Mu Opioid Agonists Inhibit Glutamatergic Input to Ventral Tegmental Area Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00855.2004 · Cited by 89 · see citing works
Adrenal steroid influences on the survival of hippocampal neurons
McEwen, B. S., & Gould, E. A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90079-z · Cited by 89 · see citing works
Retrograde Opioid Signaling Regulates Glutamatergic Transmission in the Hypothalamus
Iremonger, K. J., & Bains, J. S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0381-09.2009 · Cited by 89 · see citing works
Mitogenic Signaling via Endogenous κ‐Opioid Receptors in C6 Glioma Cells
Bohn, L., Belcheva, M. M., & Coscia, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740564.x · Cited by 89 · see citing works
Carmo, G. P. D., Stevenson, G. W., Carlezon, W. A., & Negus, S. S. (2009) · Pain · doi:10.1016/j.pain.2009.04.010 · Cited by 88 · see citing works
Self-citationTerman, G. W., Wagner, J. J., & Chavkin, C. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04740.1994 · Cited by 85 · see citing works
Zhang, H., Shi, Y., Woods, J. H., Watson, S. J., & Ko, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.045 · Cited by 85 · see citing works
Long term κ-opioid receptor blockade following nor-binaltorphimine
Jones, D. N. C., & Holtzman, S. G. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90055-9 · Cited by 85 · see citing works
Ur, E., Wright, D. M., Bouloux, P. M., & Grossman, A. B. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700971 · Cited by 84 · see citing works
Bruchas, M. R., Xu, M., & Chavkin, C. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32830dd655 · Cited by 83 · see citing works
Neuropathic pain: the paradox of dynorphin.
Lai, J., Ossipov, M. H., Vanderah, T. W., et al. (2001) · PubMed · Cited by 83 · see citing works
Simmons, M. L., & Chavkin, C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09167-9 · Cited by 81 · see citing works
Goody, R. J., Oakley, S. M., Filliol, D., Kieffer, B. L., & Kitchen, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02452-6 · Cited by 80 · see citing works
Winkler, C. W., Hermes, S. M., Chavkin, C., et al. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00676.2006 · Cited by 80 · see citing works
Watanabe, Y., Weiland, N. G., & McEwen, B. S. (1995) · Brain Research · doi:10.1016/0006-8993(95)00235-i · Cited by 79 · see citing works
Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue
Chartoff, E. H., Papadopoulou, M., MacDonald, M. L., Parsegian, A., Potter, D. N., Konradi, C. L., & Carlezon, W. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051417 · Cited by 79 · see citing works
Self-citationAntidepressant-like effects of cytidine in the forced swim test in rats
Carlezon, W. A., Pliakas, A. M., Parow, A. M., Detke, M. J., Cohen, B. M., & Renshaw, P. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01344-0 · Cited by 75 · see citing works
Self-citationBuckingham, J. C., & Cooper, T. A. (2008) · Neuroendocrinology · doi:10.1159/000124618 · Cited by 75 · see citing works
Gehrke, B. J., Chefer, V. I., & Shippenberg, T. S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1067-6 · Cited by 75 · see citing works
Dynorphin and stress‐related peptides in rat locus coeruleus: Contribution of amygdalar efferents
Reyes, B. A. S., Drolet, G., & Bockstaele, E. J. V. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21683 · Cited by 73 · see citing works
Kuzmin, A., Madjid, N., Terenius, L. Y., Ögren, S. O., & Bakalkin, G. Y. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300959 · Cited by 67 · see citing works
Prodynorphin storage and processing in axon terminals and dendrites
Yakovleva, T., Bazov, I., Cebers, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6174fje · Cited by 66 · see citing works
Brain Reward Regulated by AMPA Receptor Subunits in Nucleus Accumbens Shell
Todtenkopf, M. S., Parsegian, A., Naydenov, A. V., Neve, R. L., Konradi, C. L., & Carlezon, W. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3070-06.2006 · Cited by 65 · see citing works
Self-citationShuster, S. J., Riedl, M. S., Li, X., Vulchanova, L., & Elde, R. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00472-8 · Cited by 65 · see citing works
Sante, A. B., Nobre, M. J., & Brandão, M. L. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200011000-00005 · Cited by 60 · see citing works
Przewłocki, R., Lasoń, W., ̈llt, V. H., Silberring, J., & Herz, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91012-2 · Cited by 60 · see citing works
Cho, H. J., & Basbaum, A. I. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902810204 · Cited by 60 · see citing works
Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
Shippenberg, T. S., LeFevour, A., & Chefer, V. I. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58 · see citing works
CREB Gene Transcription Factors: Role in Molecular Mechanisms of Alcohol and Drug Addiction
Pandey, S. C., Chartoff, E. H., Carlezon, W. A., Zou, J., Zhang, H., Kreibich, A. S., Blendy, J. A., & Crews, F. T. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000153550.31168.1d · Cited by 58 · see citing works
Self-citationμ-Opioids disinhibit and κ-opioids inhibit serotonin efflux in the dorsal raphe nucleus
Tao, R., & Auerbach, S. B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.076 · Cited by 57 · see citing works
Feedback inhibition of opioid peptide release in the hypothalamus of the rat
Nikolarakis, K. E., Almeida, O. F. X., & Herz, A. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90278-8 · Cited by 57 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- American Psychiatric Association DSM-IV-TR 2000 Diagnostic and statistical manual of mental disorders 4 text revision Edition Washington, DC
Cited by
Sorted by citations
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067 · see citing works
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542 · see citing works
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504 · see citing works
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483 · see citing works
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477 · see citing works
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397 · see citing works
Alcohol dependence as a chronic pain disorder
Egli, M., Koob, G. F., & Edwards, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.010 · Cited by 347 · see citing works
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230 · see citing works
The molecular and cellular mechanisms of depression: a focus on reward circuitry
Fox, M. E., & Lobo, M. K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0415-3 · Cited by 232 · see citing works
Massaly, N., Copits, B. A., Wilson-Poe, A. R., Hipólito, L., Markovic, T., Yoon, H. J., Liu, S., Walicki, M. C., Bhatti, D. L., Sirohi, S., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.029 · Cited by 200 · see citing works
Influence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191 · see citing works
Lecca, S., Pelosi, A., Tchenio, A., Moutkine, I., Lujan, R., Hervé, D., & Mameli, M. (2016) · Nature Medicine · doi:10.1038/nm.4037 · Cited by 176 · see citing works
Evaluation of Opioid Modulation in Major Depressive Disorder
Ehrich, E., Turncliff, R., Du, Y., Leigh-Pemberton, R., Fernandez, E., Jones, R., & Fava, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.330 · Cited by 169 · see citing works
Serafini, G., Adavastro, G., Canepa, G., De Berardis, D., Valchera, A., Pompili, M., Nasrallah, H., & Amore, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082410 · Cited by 162 · see citing works
The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145 · see citing works
Kappa Opioid Receptors Regulate Stress-Induced Cocaine Seeking and Synaptic Plasticity
Graziane, N. M., Polter, A. M., Briand, L. A., Pierce, R. C., & Kauer, J. A. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.034 · Cited by 121 · see citing works
Zellner, M. R., Watt, D. F., Solms, M., & Panksepp, J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.01.003 · Cited by 112 · see citing works
Does the kappa opioid receptor system contribute to pain aversion?
Cahill, C. M., Taylor, A. M. W., Cook, C., Ong, E., Morón, J. A., & Evans, C. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00253 · Cited by 105 · see citing works
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
Nemeth, C. L., Paine, T. A., Rittiner, J. E., Béguin, C., Carroll, F. I., Roth, B. L., Cohen, B. M., & Carlezon, W. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1834-7 · Cited by 104 · see citing works
Self-citationNation, K. M., De Felice, M., Hernandez, P. I., Dodick, D. W., Neugebauer, V., Navratilova, E., & Porreca, F. (2018) · Pain · doi:10.1097/j.pain.0000000000001167 · Cited by 96 · see citing works
Epigenetic Regulation of the Kappa Opioid Receptor by Child Abuse
Lutz, P.-E., Gross, J. A., Dhir, S. K., Maussion, G., Yang, J., Bramoulle, A., Meaney, M. J., & Turecki, G. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.012 · Cited by 96 · see citing works
Leitl, M. D., Onvani, S., Bowers, M. S., Cheng, K., Rice, K. C., Carlezon, W. A., Banks, M. L., & Negus, S. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.236 · Cited by 87 · see citing works
Self-citationBailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89 · see citing works
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75 · see citing works
The Anti-Suicidal Potential of Buprenorphine: A Case Report
Striebel, J. M., & Kalapatapu, R. K. (2014) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.47.2.g · Cited by 31 · see citing works
Lee, H. H., Blumberger, D. M., Lenze, E. J., Anderson, S. J., Barch, D. M., Black, K. J., Cristancho, P., Daskalakis, Z. J., Eisenstein, S. A., Huang, Y., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.09.003 · Cited by 15 · see citing works
- Authors
- Knoll, A. T., & Carlezon, W. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carlezon, William A.
- ORCID
- Carlezon, William A.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 1314
- Pages
- 56-73
- ISSN
- 0006-8993 (ISSN-L)
- PMC
- PMC2819644
- OpenAlex
- W2029584624
- Cited by
- 465
- References
- 227
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 25 · 2023: 25 · 2022: 33 · 2021: 28 · 2020: 24 · 2019: 38 · 2018: 36 · 2017: 24 · 2016: 33 · 2015: 30 · 2014: 30 · 2013: 40 · 2012: 32
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01mh063266-25)
- National Institute of Mental Health (MH063266, R01-MH063266, F31MH078473, MH078473)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- dynorphin, kappa opioid receptor, stress, depression, chronic stress, aversive behavior, stress sensitization, anxiety disorders, limbic system, analgesia, escape motivation
- MeSH terms
- Animals, Brain, Chronic Disease, Depressive Disorder, Disease Models, Animal, Dynorphins, Fear, Humans, Narcotic Antagonists, Stress, Psychological, Comorbidity, Receptors, Opioid, kappa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review